Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids...

from Springer Nature · host Springer Nature

Bronchopulmonary Dysplasia (BPD) is a form of Chronic lung disease and results from extreme pre-term birth. Systemic corticosteroid therapy is used postnatally to reduce the severity of BPD, however there is a large range in the phenotypic response to this treatment. In this episode, we speak to Tamorah Lewis, a neonatologist at Children's Mercy Hospital in Kansas City, who aimed to identify pharmacogenetic variants associated with the clinical response to systemic corticosteroid treatment. Related article: https://www.nature.com/articles/s41390-018-0235-1

Episode metadata supplied by the publisher feed · Published Mar 8, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids...

0:00 11:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 11 minutes long.

When was this Springer Nature episode published?

This episode was published on March 8, 2019.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!